Solid Biosciences Inc. — Director's Dealing 2022

Mar 15, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Solid Biosciences Inc. (SLDB)
CIK: 0001707502
Period of Report: 2022-03-14

Reporting Person: Morris Carl Ashley (Chief Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-03-14	Common Stock	S	11269	$1.10	Disposed	266605	Direct
2022-03-14	Common Stock	S	11396	$1.10	Disposed	255209	Direct

Footnotes

F1: This sale was made to cover withholding taxes following the vesting of the previously granted restricted stock units. The shares were sold pursuant to a written instruction under Rule 10b5-1(c)(1).

F2: Includes 2,272 shares acquired by Mr. Morris under the Solid Biosciences Employee Stock Purchase Plan on November 30, 2021.